Advanced Search
Display options
Filter resources
Text Availability
Article type
Publication date
Species
Language
Sex
Age
Showing 1 to 12 of 1140 entries
Sorted by: Best Match Show Resources per page
Validation of the European Organization for Research and Treatment of Cancer cervical cancer module for Chinese patients with cervical cancer.

Patient preference and adherence

Hua CH, Guo HM, Guan XL, Kong FJ, Hou RJ, Zhang XY, Li SR.
PMID: 24204125
Patient Prefer Adherence. 2013 Oct 17;7:1061-6. doi: 10.2147/PPA.S52498. eCollection 2013.

PURPOSE: The aim of our study was to assess, for the first time, the validity, reliability, and acceptability of the European Organization for Research and Treatment of Cancer (EORTC) Quality of Life questionnaire (QLQ) cervical cancer module (CX24) in...

Cite
Hua CH, Guo HM, Guan XL, et al. Validation of the European Organization for Research and Treatment of Cancer cervical cancer module for Chinese patients with cervical cancer. Patient Prefer Adherence. 2013;7:1061-6doi: 10.2147/PPA.S52498.
Hua, C. H., Guo, H. M., Guan, X. L., Kong, F. J., Hou, R. J., Zhang, X. Y., & Li, S. R. (2013). Validation of the European Organization for Research and Treatment of Cancer cervical cancer module for Chinese patients with cervical cancer. Patient preference and adherence, 71061-6. https://doi.org/10.2147/PPA.S52498
Hua, Cai-Hong, et al. "Validation of the European Organization for Research and Treatment of Cancer cervical cancer module for Chinese patients with cervical cancer." Patient preference and adherence vol. 7 (2013): 1061-6. doi: https://doi.org/10.2147/PPA.S52498
Hua CH, Guo HM, Guan XL, Kong FJ, Hou RJ, Zhang XY, Li SR. Validation of the European Organization for Research and Treatment of Cancer cervical cancer module for Chinese patients with cervical cancer. Patient Prefer Adherence. 2013 Oct 17;7:1061-6. doi: 10.2147/PPA.S52498. eCollection 2013. PMID: 24204125; PMCID: PMC3804534.
Copy Download .nbib Format: NLM
Survival Benefit of Locoregional Treatment for Hepatocellular Carcinoma with Advanced Liver Cirrhosis.

Liver cancer

Kitai S, Kudo M, Nishida N, Izumi N, Sakamoto M, Matsuyama Y, Ichida T, Nakashima O, Matsui O, Ku Y, Kokudo N, Makuuchi M.
PMID: 27493893
Liver Cancer. 2016 Jul;5(3):175-89. doi: 10.1159/000367765. Epub 2016 May 03.

BACKGROUND & AIMS: Hepatocellular carcinoma (HCC) with decompensated liver cirrhosis (LC) is a life-threatening condition, which is amenable to liver transplantation (LT) as the standard first-line treatment. However, the application of LT can be limited due to a shortage...

Cite
Kitai S, Kudo M, Nishida N, et al. Survival Benefit of Locoregional Treatment for Hepatocellular Carcinoma with Advanced Liver Cirrhosis. Liver Cancer. 2016;5(3):175-89doi: 10.1159/000367765.
Kitai, S., Kudo, M., Nishida, N., Izumi, N., Sakamoto, M., Matsuyama, Y., Ichida, T., Nakashima, O., Matsui, O., Ku, Y., Kokudo, N., Makuuchi, M. (2016). Survival Benefit of Locoregional Treatment for Hepatocellular Carcinoma with Advanced Liver Cirrhosis. Liver cancer, 5(3), 175-89. https://doi.org/10.1159/000367765
Kitai, Satoshi, et al. "Survival Benefit of Locoregional Treatment for Hepatocellular Carcinoma with Advanced Liver Cirrhosis." Liver cancer vol. 5,3 (2016): 175-89. doi: https://doi.org/10.1159/000367765
Kitai S, Kudo M, Nishida N, Izumi N, Sakamoto M, Matsuyama Y, Ichida T, Nakashima O, Matsui O, Ku Y, Kokudo N, Makuuchi M. Survival Benefit of Locoregional Treatment for Hepatocellular Carcinoma with Advanced Liver Cirrhosis. Liver Cancer. 2016 Jul;5(3):175-89. doi: 10.1159/000367765. Epub 2016 May 03. PMID: 27493893; PMCID: PMC4960362.
Copy Download .nbib Format: NLM
Perioperative Pain Management in Total Hip Arthroplasty: Korean Hip Society Guidelines.

Hip & pelvis

Min BW, Kim Y, Cho HM, Park KS, Yoon PW, Nho JH, Kim SM, Lee KJ, Moon KH.
PMID: 27536639
Hip Pelvis. 2016 Mar;28(1):15-23. doi: 10.5371/hp.2016.28.1.15. Epub 2016 Mar 31.

Effective perioperative pain management techniques and accelerated rehabilitation programs can improve health-related quality of life and functional status of patients after total hip arthroplasty. Traditionally, postoperative analgesia following arthroplasty was provided by intravenous patient-controlled analgesia or epidural analgesia. Recently,...

Cite
Min BW, Kim Y, Cho HM, et al. Perioperative Pain Management in Total Hip Arthroplasty: Korean Hip Society Guidelines. Hip Pelvis. 2016;28(1):15-23doi: 10.5371/hp.2016.28.1.15.
Min, B. W., Kim, Y., Cho, H. M., Park, K. S., Yoon, P. W., Nho, J. H., Kim, S. M., Lee, K. J., & Moon, K. H. (2016). Perioperative Pain Management in Total Hip Arthroplasty: Korean Hip Society Guidelines. Hip & pelvis, 28(1), 15-23. https://doi.org/10.5371/hp.2016.28.1.15
Min, Byung-Woo, et al. "Perioperative Pain Management in Total Hip Arthroplasty: Korean Hip Society Guidelines." Hip & pelvis vol. 28,1 (2016): 15-23. doi: https://doi.org/10.5371/hp.2016.28.1.15
Min BW, Kim Y, Cho HM, Park KS, Yoon PW, Nho JH, Kim SM, Lee KJ, Moon KH. Perioperative Pain Management in Total Hip Arthroplasty: Korean Hip Society Guidelines. Hip Pelvis. 2016 Mar;28(1):15-23. doi: 10.5371/hp.2016.28.1.15. Epub 2016 Mar 31. PMID: 27536639; PMCID: PMC4972874.
Copy Download .nbib Format: NLM
The dynamics of nucleation and growth of a particle in the ternary alloy melt with anisotropic surface tension.

The Journal of chemical physics

Chen MW, Li LY, Guo HM.
PMID: 28863507
J Chem Phys. 2017 Aug 28;147(8):084707. doi: 10.1063/1.4999341.

The dynamics of nucleation and growth of a particle affected by anisotropic surface tension in the ternary alloy melt is studied. The uniformly valid asymptotic solution for temperature field, concentration field, and interface evolution of nucleation and particle growth...

Cite
Chen MW, Li LY, Guo HM. The dynamics of nucleation and growth of a particle in the ternary alloy melt with anisotropic surface tension. J Chem Phys. 2017;147(8):084707doi: 10.1063/1.4999341.
Chen, M. W., Li, L. Y., & Guo, H. M. (2017). The dynamics of nucleation and growth of a particle in the ternary alloy melt with anisotropic surface tension. The Journal of chemical physics, 147(8), 084707. https://doi.org/10.1063/1.4999341
Chen, Ming-Wen, et al. "The dynamics of nucleation and growth of a particle in the ternary alloy melt with anisotropic surface tension." The Journal of chemical physics vol. 147,8 (2017): 084707. doi: https://doi.org/10.1063/1.4999341
Chen MW, Li LY, Guo HM. The dynamics of nucleation and growth of a particle in the ternary alloy melt with anisotropic surface tension. J Chem Phys. 2017 Aug 28;147(8):084707. doi: 10.1063/1.4999341. PMID: 28863507.
Copy Download .nbib Format: NLM
Five-year epidemiological survey of valvular heart disease: changes in morbidity, etiological spectrum and management in a cardiovascular center of Southern China.

Journal of thoracic disease

Liu FZ, Xue YM, Liao HT, Zhan XZ, Guo HM, Huang HL, Fang XH, Wei W, Rao F, Deng H, Liu Y, Lin WD, Wu SL.
PMID: 25589965
J Thorac Dis. 2014 Dec;6(12):1724-30. doi: 10.3978/j.issn.2072-1439.2014.11.21.

OBJECTIVE: The objective of the present study is to analyze the epidemiological profile of patients with abnormal valvular structure and function and highlight the etiological spectrum and management of valvular heart disease (VHD) in a single cardiovascular center of...

Cite
Liu FZ, Xue YM, Liao HT, et al. Five-year epidemiological survey of valvular heart disease: changes in morbidity, etiological spectrum and management in a cardiovascular center of Southern China. J Thorac Dis. 2014;6(12):1724-30doi: 10.3978/j.issn.2072-1439.2014.11.21.
Liu, F. Z., Xue, Y. M., Liao, H. T., Zhan, X. Z., Guo, H. M., Huang, H. L., Fang, X. H., Wei, W., Rao, F., Deng, H., Liu, Y., Lin, W. D., & Wu, S. L. (2014). Five-year epidemiological survey of valvular heart disease: changes in morbidity, etiological spectrum and management in a cardiovascular center of Southern China. Journal of thoracic disease, 6(12), 1724-30. https://doi.org/10.3978/j.issn.2072-1439.2014.11.21
Liu, Fang-Zhou, et al. "Five-year epidemiological survey of valvular heart disease: changes in morbidity, etiological spectrum and management in a cardiovascular center of Southern China." Journal of thoracic disease vol. 6,12 (2014): 1724-30. doi: https://doi.org/10.3978/j.issn.2072-1439.2014.11.21
Liu FZ, Xue YM, Liao HT, Zhan XZ, Guo HM, Huang HL, Fang XH, Wei W, Rao F, Deng H, Liu Y, Lin WD, Wu SL. Five-year epidemiological survey of valvular heart disease: changes in morbidity, etiological spectrum and management in a cardiovascular center of Southern China. J Thorac Dis. 2014 Dec;6(12):1724-30. doi: 10.3978/j.issn.2072-1439.2014.11.21. PMID: 25589965; PMCID: PMC4283290.
Copy Download .nbib Format: NLM
Detection of tumor vascularity in hepatocellular carcinoma with contrast-enhanced Dynamic Flow imaging: Comparison with contrast-enhanced power Doppler imaging.

Journal of medical ultrasonics (2001)

Wen YL, Kudo M, Minami Y, Chung H, Suetomi Y, Onda H, Kitano M, Kawasaki T, Maekawa K.
PMID: 27278304
J Med Ultrason (2001). 2003 Sep;30(3):141-51. doi: 10.1007/BF02481219.

OBJECTIVE: To compare the effectiveness of contrast-enhanced Dynamic Flow imaging and contrast-enhanced power Doppler imaging using Levovist(®) as a microbubble contrast agent in evaluating intratumoral vascularity in hepatocellular carcinoma (HCC).MATERIALS AND METHODS: Twenty-nine patients with 54 hepatocellular carcinoma nodules...

Cite
Wen YL, Kudo M, Minami Y, et al. Detection of tumor vascularity in hepatocellular carcinoma with contrast-enhanced Dynamic Flow imaging: Comparison with contrast-enhanced power Doppler imaging. J Med Ultrason (2001). 2003;30(3):141-51doi: 10.1007/BF02481219.
Wen, Y. L., Kudo, M., Minami, Y., Chung, H., Suetomi, Y., Onda, H., Kitano, M., Kawasaki, T., & Maekawa, K. (2003). Detection of tumor vascularity in hepatocellular carcinoma with contrast-enhanced Dynamic Flow imaging: Comparison with contrast-enhanced power Doppler imaging. Journal of medical ultrasonics (2001), 30(3), 141-51. https://doi.org/10.1007/BF02481219
Wen, Yan Ling, et al. "Detection of tumor vascularity in hepatocellular carcinoma with contrast-enhanced Dynamic Flow imaging: Comparison with contrast-enhanced power Doppler imaging." Journal of medical ultrasonics (2001) vol. 30,3 (2003): 141-51. doi: https://doi.org/10.1007/BF02481219
Wen YL, Kudo M, Minami Y, Chung H, Suetomi Y, Onda H, Kitano M, Kawasaki T, Maekawa K. Detection of tumor vascularity in hepatocellular carcinoma with contrast-enhanced Dynamic Flow imaging: Comparison with contrast-enhanced power Doppler imaging. J Med Ultrason (2001). 2003 Sep;30(3):141-51. doi: 10.1007/BF02481219. PMID: 27278304.
Copy Download .nbib Format: NLM
Diagnosis of acute cholecystitis in patients with liver cirrhosis: waveform analysis of the cystic artery by color Doppler imaging.

Journal of medical ultrasonics (2001)

Tochio H, Nishiuma S, Okabe Y, Orino A, Kudo M.
PMID: 27278492
J Med Ultrason (2001). 2004 Mar;31(1):21-8. doi: 10.1007/s10396-003-0001-8.

PURPOSE: The aim of this study was to investigate the possibility of diagnosing acute cholecystitis in patients with liver cirrhosis using color Doppler imaging to demonstrate the hemodynamics.METHODS: Color Doppler imaging was used to analyze the waveform of the...

Cite
Tochio H, Nishiuma S, Okabe Y, et al. Diagnosis of acute cholecystitis in patients with liver cirrhosis: waveform analysis of the cystic artery by color Doppler imaging. J Med Ultrason (2001). 2004;31(1):21-8doi: 10.1007/s10396-003-0001-8.
Tochio, H., Nishiuma, S., Okabe, Y., Orino, A., & Kudo, M. (2004). Diagnosis of acute cholecystitis in patients with liver cirrhosis: waveform analysis of the cystic artery by color Doppler imaging. Journal of medical ultrasonics (2001), 31(1), 21-8. https://doi.org/10.1007/s10396-003-0001-8
Tochio, Hitoshi, et al. "Diagnosis of acute cholecystitis in patients with liver cirrhosis: waveform analysis of the cystic artery by color Doppler imaging." Journal of medical ultrasonics (2001) vol. 31,1 (2004): 21-8. doi: https://doi.org/10.1007/s10396-003-0001-8
Tochio H, Nishiuma S, Okabe Y, Orino A, Kudo M. Diagnosis of acute cholecystitis in patients with liver cirrhosis: waveform analysis of the cystic artery by color Doppler imaging. J Med Ultrason (2001). 2004 Mar;31(1):21-8. doi: 10.1007/s10396-003-0001-8. PMID: 27278492.
Copy Download .nbib Format: NLM
Inducible HGF-secreting Human Umbilical Cord Blood-derived MSCs Produced via TALEN-mediated Genome Editing Promoted Angiogenesis.

Molecular therapy : the journal of the American Society of Gene Therapy

Chang HK, Kim PH, Cho HM, Yum SY, Choi YJ, Son Y, Lee D, Kang I, Kang KS, Jang G, Cho JY.
PMID: 27434585
Mol Ther. 2016 Sep;24(9):1644-54. doi: 10.1038/mt.2016.120. Epub 2016 Jun 10.

Mesenchymal stem cells (MSCs) promote therapeutic angiogenesis to cure serious vascular disorders. However, their survival period and cytokine-secretory capacity are limited. Although hepatocyte growth factor (HGF) can accelerate the rate of angiogenesis, recombinant HGF is limited because of its...

Cite
Chang HK, Kim PH, Cho HM, et al. Inducible HGF-secreting Human Umbilical Cord Blood-derived MSCs Produced via TALEN-mediated Genome Editing Promoted Angiogenesis. Mol Ther. 2016;24(9):1644-54doi: 10.1038/mt.2016.120.
Chang, H. K., Kim, P. H., Cho, H. M., Yum, S. Y., Choi, Y. J., Son, Y., Lee, D., Kang, I., Kang, K. S., Jang, G., & Cho, J. Y. (2016). Inducible HGF-secreting Human Umbilical Cord Blood-derived MSCs Produced via TALEN-mediated Genome Editing Promoted Angiogenesis. Molecular therapy : the journal of the American Society of Gene Therapy, 24(9), 1644-54. https://doi.org/10.1038/mt.2016.120
Chang, Hyun-Kyung, et al. "Inducible HGF-secreting Human Umbilical Cord Blood-derived MSCs Produced via TALEN-mediated Genome Editing Promoted Angiogenesis." Molecular therapy : the journal of the American Society of Gene Therapy vol. 24,9 (2016): 1644-54. doi: https://doi.org/10.1038/mt.2016.120
Chang HK, Kim PH, Cho HM, Yum SY, Choi YJ, Son Y, Lee D, Kang I, Kang KS, Jang G, Cho JY. Inducible HGF-secreting Human Umbilical Cord Blood-derived MSCs Produced via TALEN-mediated Genome Editing Promoted Angiogenesis. Mol Ther. 2016 Sep;24(9):1644-54. doi: 10.1038/mt.2016.120. Epub 2016 Jun 10. PMID: 27434585; PMCID: PMC5113099.
Copy Download .nbib Format: NLM
Septicemia due to Vibrio cholerae serogroup non-O1/non-O139 strain in a cirrhotic patient.

Clinical journal of gastroenterology

Inoue T, Kitai S, Hayaishi S, Kudo M.
PMID: 26181318
Clin J Gastroenterol. 2012 Dec;5(6):383-7. doi: 10.1007/s12328-012-0332-3. Epub 2012 Oct 29.

We describe a case of non-O1/ non-O139 Vibrio cholerae septicemia in a 65-year-old male patient with alcoholic liver cirrhosis. He was admitted due to septic shock from non-O1/ non-O139 V. cholerae. An intravenous empiric antibiotic, ceftriaxone sodium hydrate, was...

Cite
Inoue T, Kitai S, Hayaishi S, et al. Septicemia due to Vibrio cholerae serogroup non-O1/non-O139 strain in a cirrhotic patient. Clin J Gastroenterol. 2012;5(6):383-7doi: 10.1007/s12328-012-0332-3.
Inoue, T., Kitai, S., Hayaishi, S., & Kudo, M. (2012). Septicemia due to Vibrio cholerae serogroup non-O1/non-O139 strain in a cirrhotic patient. Clinical journal of gastroenterology, 5(6), 383-7. https://doi.org/10.1007/s12328-012-0332-3
Inoue, Tatsuo, et al. "Septicemia due to Vibrio cholerae serogroup non-O1/non-O139 strain in a cirrhotic patient." Clinical journal of gastroenterology vol. 5,6 (2012): 383-7. doi: https://doi.org/10.1007/s12328-012-0332-3
Inoue T, Kitai S, Hayaishi S, Kudo M. Septicemia due to Vibrio cholerae serogroup non-O1/non-O139 strain in a cirrhotic patient. Clin J Gastroenterol. 2012 Dec;5(6):383-7. doi: 10.1007/s12328-012-0332-3. Epub 2012 Oct 29. PMID: 26181318.
Copy Download .nbib Format: NLM
New Era of the Management of Liver Diseases and Liver Cancer: State-of-the-Art Progress in 2017.

Digestive diseases (Basel, Switzerland)

Kudo M.
PMID: 29040980
Dig Dis. 2017;35(6):493-497. doi: 10.1159/000480137. Epub 2017 Oct 17.

No abstract available.

Cite
Kudo M. New Era of the Management of Liver Diseases and Liver Cancer: State-of-the-Art Progress in 2017. Dig Dis. 2017;35(6):493-497doi: 10.1159/000480137.
Kudo, M. (2017). New Era of the Management of Liver Diseases and Liver Cancer: State-of-the-Art Progress in 2017. Digestive diseases (Basel, Switzerland), 35(6), 493-497. https://doi.org/10.1159/000480137
Kudo, Masatoshi. "New Era of the Management of Liver Diseases and Liver Cancer: State-of-the-Art Progress in 2017." Digestive diseases (Basel, Switzerland) vol. 35,6 (2017): 493-497. doi: https://doi.org/10.1159/000480137
Kudo M. New Era of the Management of Liver Diseases and Liver Cancer: State-of-the-Art Progress in 2017. Dig Dis. 2017;35(6):493-497. doi: 10.1159/000480137. Epub 2017 Oct 17. PMID: 29040980.
Copy Download .nbib Format: NLM
Albumin-Bilirubin Grade and Hepatocellular Carcinoma Treatment Algorithm.

Liver cancer

Kudo M.
PMID: 28626730
Liver Cancer. 2017 Jun;6(3):185-188. doi: 10.1159/000462199. Epub 2017 Mar 09.

No abstract available.

Cite
Kudo M. Albumin-Bilirubin Grade and Hepatocellular Carcinoma Treatment Algorithm. Liver Cancer. 2017;6(3):185-188doi: 10.1159/000462199.
Kudo, M. (2017). Albumin-Bilirubin Grade and Hepatocellular Carcinoma Treatment Algorithm. Liver cancer, 6(3), 185-188. https://doi.org/10.1159/000462199
Kudo, Masatoshi. "Albumin-Bilirubin Grade and Hepatocellular Carcinoma Treatment Algorithm." Liver cancer vol. 6,3 (2017): 185-188. doi: https://doi.org/10.1159/000462199
Kudo M. Albumin-Bilirubin Grade and Hepatocellular Carcinoma Treatment Algorithm. Liver Cancer. 2017 Jun;6(3):185-188. doi: 10.1159/000462199. Epub 2017 Mar 09. PMID: 28626730; PMCID: PMC5473061.
Copy Download .nbib Format: NLM
Prediction of hepatocellular carcinoma incidence risk by ultrasound elastography.

Liver cancer

Kudo M.
PMID: 24804171
Liver Cancer. 2014 Mar;3(1):1-5. doi: 10.1159/000343859.

No abstract available.

Cite
Kudo M. Prediction of hepatocellular carcinoma incidence risk by ultrasound elastography. Liver Cancer. 2014;3(1):1-5doi: 10.1159/000343859.
Kudo, M. (2014). Prediction of hepatocellular carcinoma incidence risk by ultrasound elastography. Liver cancer, 3(1), 1-5. https://doi.org/10.1159/000343859
Kudo, M. "Prediction of hepatocellular carcinoma incidence risk by ultrasound elastography." Liver cancer vol. 3,1 (2014): 1-5. doi: https://doi.org/10.1159/000343859
Kudo M. Prediction of hepatocellular carcinoma incidence risk by ultrasound elastography. Liver Cancer. 2014 Mar;3(1):1-5. doi: 10.1159/000343859. PMID: 24804171; PMCID: PMC3995376.
Copy Download .nbib Format: NLM
Showing 1 to 12 of 1140 entries